1. An adaptive biomarker basket design in phase II oncology trials. (26th September 2022) Authors: Liu, Shufang; Takeda, Kentaro; Rong, Alan Journal: Pharmaceutical statistics Issue: Volume 22:Number 1(2023) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biomarker threshold adaptive designs for survival endpoints. Issue 6 (2nd November 2018) Authors: Diao, Guoqing; Dong, Jun; Zeng, Donglin; Ke, Chunlei; Rong, Alan; Ibrahim, Joseph G Journal: Journal of biopharmaceutical statistics Issue: Volume 28:Issue 6(2018) Page Start: 1038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers. (25th October 2021) Authors: Takeda, Kentaro; Liu, Shufang; Rong, Alan Journal: Statistics in medicine Issue: Volume 41:Number 2(2022) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Estimation of delay time in survival data with delayed treatment effect. Issue 2 (4th March 2019) Authors: Li, Wei; Chen, Sophie Yu-Pu; Rong, Alan Journal: Journal of biopharmaceutical statistics Issue: Volume 29:Issue 2(2019) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer. Issue 8 (September 2015) Authors: Hecht, J. Randolph; Douillard, Jean-Yves; Schwartzberg, Lee; Grothey, Axel; Kopetz, Scott; Rong, Alan; Oliner, Kelly S.; Sidhu, Roger Journal: Cancer treatment reviews Issue: Volume 41:Issue 8(2015) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer. Issue 8 (September 2015) Authors: Hecht, J. Randolph; Douillard, Jean-Yves; Schwartzberg, Lee; Grothey, Axel; Kopetz, Scott; Rong, Alan; Oliner, Kelly S.; Sidhu, Roger Journal: Cancer treatment reviews Issue: Volume 41:Issue 8(2015) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracy. Issue 1 (December 2015) Authors: Xu, Tu; Fang, Yixin; Rong, Alan; Wang, Junhui Journal: BMC medical research methodology Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pattern mixture models for clinical validation of biomarkers in the presence of missing data. (2nd May 2017) Authors: Gao, Fei; Dong, Jun; Zeng, Donglin; Rong, Alan; Ibrahim, Joseph G. Journal: Statistics in medicine Issue: Volume 36:Number 19(2017) Page Start: 2994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effects. Issue 6 (2nd November 2017) Authors: Diao, Guoqing; Zeng, Donglin; Ibrahim, Joseph G.; Rong, Alan; Lee, Oliver; Zhang, Kathy; Chen, Qingxia Journal: Journal of biopharmaceutical statistics Issue: Volume 27:Issue 6(2017) Page Start: 933 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TITE‐gBOIN: Time‐to‐event Bayesian optimal interval design to accelerate dose‐finding accounting for toxicity grades. (3rd December 2021) Authors: Takeda, Kentaro; Xia, Qing; Liu, Shufang; Rong, Alan Journal: Pharmaceutical statistics Issue: Volume 21:Number 2(2022) Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗